Global Electroporation Instruments Market 2018-2022: Market to Grow at a CAGR of 5.64% - High Demand for Biopharmaceuticals

DUBLIN, Oct. 2, 2018 /PRNewswire/ --

The "Global Electroporation Instruments Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The Global Electroporation Instruments Market to grow at a CAGR of 5.64% during the period 2018-2022.

Global Electroporation Instruments Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the high demand for biopharmaceuticals. In the past few years, there has been an increased demand for biopharmaceutical products, especially those that are extracted from mammalian cells.

According to the report, one driver influencing this market is the growing demand for monoclonal antibodies. Monoclonal antibodies are identical immune cells and are one of the fastest growing products in the pharmaceutical industry.

Further, the report states that one challenge affecting this market are the factors affecting electroporation efficiency. Electroporation can be hampered due to the degree of confluency, the number of passages, cell health, contamination, and DNA quality.

Key vendors:

    --  Bio-Rad Laboratories
    --  Eppendorf
    --  Harvard Bioscience
    --  Lonza
    --  Thermo Fisher Scientific

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

    --  Market ecosystem
    --  Market characteristics
    --  Market segmentation analysis

PART 05: MARKET SIZING

    --  Market definition
    --  Market sizing 2017
    --  Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

    --  Bargaining power of buyers
    --  Bargaining power of suppliers
    --  Threat of new entrants
    --  Threat of substitutes
    --  Threat of rivalry
    --  Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

    --  Segmentation by end-user
    --  Comparison by end-user

    --  Pharmaceutical and biotechnology companies
    --  Academic and research institute
    --  CROs
    --  Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

    --  Geographical segmentation
    --  Regional comparison
    --  Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

    --  High demand for biopharmaceuticals
    --  Growing initiatives for molecular research activities
    --  Increasing importance of promotional activities

PART 13: VENDOR LANDSCAPE

    --  Landscape disruption

PART 14: VENDOR ANALYSIS

    --  Vendors covered
    --  Vendor classification

    --  Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/nt77q5/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-electroporation-instruments-market-2018-2022-market-to-grow-at-a-cagr-of-5-64---high-demand-for-biopharmaceuticals-300722856.html

SOURCE Research and Markets